Treatment with CD147 markedly enhanced the expression of GSDMD and GSDME proteins and activated pyroptosis to aggravate intestinal inflammation, suggesting that GSDME-mediated pyroptosis might be involved in the pathogenesis of IBD (Xu et al., 2020). This evidence concerns the gene GSDME and inflammatory bowel disease.